baber/WOPTO huggingface dataset:
Patent DE-602005000207-T2 (DE)
Inventor: FANGEAT NICOLAS
IPC: B60T8/00
Filed: 2005-01-07
Granted: 2007-09-06
Abstract: The system has a controller determining two coefficients from a number of pairs of wheel adhesion coefficient and wheel spin, to plot two variation curves. The determination is repeated for each new acquisition of the pairs, as long as a difference between average slopes of the curves, is less than a threshold. A target wheel spin is calculated using the lost pair and a mean algorithm, when the difference exceeds the threshold. One curve passes through the origin and the other does not pass through the origin. The curves include the value of the pairs, and the wheel adhesion coefficient has non-zero value.
Patent DE-602005002492-T2 (DE)
Inventor: MORETTI ROBERT
IPC: C07C35/36
Filed: 2005-05-10
Granted: 2008-06-12
Abstract: The present invention relates to the use as perfuming ingredient of a decaline derivative of formula wherein R<SUP>1 </SUP>is a lower alkyl, the R<SUP>2 </SUP>to R<SUP>5 </SUP>are hydrogen atoms or lower alkyls and at least one dotted line is a double bond, which is a useful perfuming ingredient of the woody or woody-citrus type.
Patent DE-602005005500-T2 (DE)
Inventor: HORACEK PETR
IPC: B60H1/32
Filed: 2005-12-09
Granted: 2009-04-23
Abstract: A condensate draining assembly comprises a housing (6) which has a condensate evacuation part (8) with a pipe (10). The condensate evacuation part (8) comprises a flexible part (9) connecting said pipe (10) to said housing (6), which is moveable between a transport position (P1) wherein said pipe (10) extends substantially within the housing (6) and a delivery position wherein said pipe (10) substantially protrudes from said housing (6).  A heating, ventilating and/or air conditioning device of an automotive vehicle comprises such an assembly.  Application to automotive vehicles.
Patent DE-602005006049-T2 (DE)
Inventor: SHELTON FREDERICK E
IPC: A61B17/28
Filed: 2005-06-29
Granted: 2009-05-07
Abstract: A surgical stapling and severing instrument particularly suited to endoscopic procedures incorporates a handle that produces separate closing and firing motions to actuate an end effector. In particular, the handle produces multiple firing strokes in order to reduce the required amount of force required to fire (i.e., staple and sever) the end effector. Varying the center of rotation, circumferential length, and depth of cam lobes in a cam disk that interacts with the firing trigger via a drive wedge allows optimization. In particular, mechanical advantages during specific firing strokes mitigates increased force to fire at the end effector, enabling a more uniform tactile force at the firing trigger.
Patent DE-602005006125-T2 (DE)
Inventor: LEBUGLE DENIS
IPC: B29D24/00
Filed: 2005-05-13
Granted: 2009-06-10
Abstract: The invention relates to a method for producing a sandwich-type composite structure consisting in producing a three-dimensional blank (E) for forming a central core of said composite structure by means of a rigid form (1), in placing a plurality of joining spherical hollow balls (10.1, 10.2,... 10.i...) according to selected diameters and geometrical arrangement which are determined by calculation, wherein each ball is deformable and contains at least one type of functional agent, in securing the spherical balls in the respective positions thereof in such a way that a non-rigid unitary handable assembly which forms the three-dimensional blank (E) is produced. The thus produced three-dimensional blank (E) is, afterwards, disposed between two skins (20, 21) and the assembly is placed in a hot pressing mould (M) in order to obtain a composite structure (S) whose internal honeycomb core (32) is formed by shaping the balls of said three-dimensional blank. A composite structure obtainable by the inventive method is also disclosed.
Patent DE-60112472-T3 (DE)
Inventor: LANGLEY CHRISTOPHER
IPC: A61M5/315
Filed: 2001-12-21
Granted: 2016-08-11
Abstract: An injection device having a drive mechanism to expel selectively a dose of medicament from a medicament cartridge through a needle unit is disclosed. The injection device further comprises an electronic control unit to control the drive mechanism, and a dispense button to generate a dispense button signal to the electronic control unit indicative of the dose to be expelled in which an arm button causes a first arm button signal to be sent to the electronic control unit to permit the dose to be expelled.
Patent DE-60121361-T3 (DE)
Inventor: DESCOUTS PIERRE
IPC: A61B17/58
Filed: 2001-11-19
Granted: 2012-01-05
Abstract: Compounds having phosphonic acid groups or a derivative thereof, corresponding to the general formula (I)  
 A-[P(O)(OH) 2 ] p (I),  
or a pharmaceutically acceptable derivative thereof, wherein A means a residue of a linear, branched or cyclic, saturated or unsaturated, hydrocarbon residue with n carbon atoms, whereby said residue may be substituted by hydroxyl and/or carboxyl and optionally further interrupted by one or more oxygen and/or sulphur and/or nitrogen atoms, carrying p phosphonic acid groups, wherein n is a number from 4 to 70, and p is 3, 4, 5 or 6, are especially suitable to treat surfaces of Endosseous implants to be applied to a human or animal bone to improve osseointegration.
Patent DE-60310944-T3 (DE)
Inventor: GIESE KLAUS
IPC: C12Q1/68
Filed: 2003-08-05
Granted: 2017-08-03
Abstract: The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double- stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended.
Patent DK-1167317-T3 (DK)
Inventor: SOMMER MARCEL
IPC: C04B24/32
Filed: 2000-06-21
Granted: 2004-04-05
Abstract: Binding and hardening accelerator consists of a water-soluble fluoride-containing and sulfate-containing aluminum salt.
Patent DK-1159179-T3 (DK)
Inventor: ROTZ TIMOTHY JAMES
IPC: B60T11/10
Filed: 2000-03-06
Granted: 2006-04-18
Abstract: A braking system controlled by an operator's pedal for a vehicle equipped with a mechanically actuated brake clutch pack in which a cam is rotated in response to movement of a brake pedal to operate a pressure-modulating hydraulic valve to direct fluid pressure to an hydraulic actuator extendable under pressure to engage a force transfer member secured to an actuator rod, which rod is connected to apply the clutch pack when tensioned.
Patent DK-1192234-T3 (DK)
Inventor: KRUMM WOLFGANG
IPC: B09B3/00
Filed: 2000-06-27
Granted: 2010-04-12
Abstract: An apparatus for pyrolysis and gasification of organic substances and mixtures thereof is provided with a pyrolysis reactor ( 1 ), a fluidized-bed firing ( 3 ) for pyrolysis residue, a reaction zone ( 2 ) for the pyrolysis gases ( 13 ) and circulating fluidized-bed material ( 35 ). The pyrolysis reactor ( 1 ) has a sluice for introducing application material ( 10 ) thereinto. An inlet for the fluidized-bed material ( 35 ) is disposed next to the combustion fluidized bed ( 3 ). Transport apparatus ( 14 ) for mixture of solid pyrolysis residue and circulating fluidized bed material ( 35 ) is disposed at or near a bottom of the fluidized bed ( 3 ) and lower end of the pyrolysis reactor ( 1 ). An overflow is situated at or near the top of the fluidized bed ( 3 ) while a heat transfer member is positioned within the reaction zone ( 2 ).
Patent DK-1230354-T3 (DK)
Inventor: KOCHANEK STEFAN
IPC: C12N15/00
Filed: 2000-11-07
Granted: 2004-03-22
Abstract: Die Erfindung betrifft eine permanente Amniozyten-Zelllinie, enthaltend mindestens eine Nukleinsäure, die die Expression der Genprodukte der E1A- und E1B-Region von Adenovirus bewirkt. Weiterhin betrifft die vorliegende Erfindung die Herstellung einer permanenten Amniozyten-Zelllinie und ihre Verwendung zur Herstellung von Gentransfer-Vektoren. Weitere Aspekte sind die Verwendung von Amniozyten bzw. der adenoviralen Genprodukte der E1A- und E1B-Region zur Herstellung von permanenten Amniozyten-Zelllinien.
Patent DK-1239732-T3 (DK)
Inventor: DE HAAN BEN RUDOLF
IPC: A23B4/10
Filed: 2000-12-20
Granted: 2004-06-14
Abstract: The present invention provides a method for preserving the activity of a polyene fungicide in an aqueous solution comprising providing the said aqueous solution with a chelating agent and/or an anti-oxidation agent, wherein the said chelating agent and the said anti-oxidation agent are the same agent or are different agents. Preferably, the aqueous solution further comprises a polymer. Preferably, the aqueous solution comprises a latex. The invention allows the selection of a wider range of polymer compositions for the preparation of a polymer emulsion comprising a polyene fungicide, wherein the activity of the said fungicide is at least in part stable and wherein the said emulsion is suited for the production of food coatings.
Patent DK-1278874-T3 (DK)
Inventor: JIANG WEN G
IPC: A61K35/76
Filed: 2001-05-04
Granted: 2010-03-29
Abstract: An isolated, purified or recombinant nucleic acid sequence is disclosed, comprising: (a) a sequence that encodes both an angiogenic factor antagonist and a vascular endothelial structure regulator; (b) a sequence substantially homologous to or that hybridizes to sequence (a) under stringent conditions; or (c) a sequence substantially homologous to or that hybridizes under stringent conditions to the sequence (a) or (b) but for the degeneracy of the genetic code; or (g) an oligonucleotide specific for any of the sequences (a), (b) or (c). Particular oligonucleotides (d) are those encoding the vascular endothelial structure regulator. Also described are methods for preparing the recombinant polynucleotide, proteins encoded by such polynucleotides and their use in gene or protein therapy for the treatment of conditions such as cancer.
Patent DK-1238986-T3 (DK)
Inventor: FERRARA NAPOLEONE
IPC: C07K16/22
Filed: 1992-10-28
Granted: 2008-09-29
Abstract: (A) A compsn. is claimed comprising a human vascular endothelial growth factor (hVEGF) antagonist, provided however that the antagonist is not the flt or flk-1 or KOR receptor or a neutralising anti-hVEGF antibody. Also claimed are: (B) a monoclonal antibody (MAb) amino acid sequence capable of specifically binding to a HVEGF receptor (hVEGFr) or a hVEGF-hVEGFr; (C) a polypeptide comprising an amino acid sequence comprising a bVEGFr and an immunoglobulin chain; (D) a method of treatment of a tumour in a mammal comprising administering a HVEGF antagonist to reduce the size of the tumour.
Patent DK-1281655-T3 (DK)
IPC: B66B13/30
Filed: 2002-07-08
Granted: 2004-03-08
Abstract: Lift well door comprises a door frame, a door leaf (1) made from panels (2, 3) guided on a runner (5), and rails (9) for guiding the runner arranged in the upper sleeper (21) of the frame. The panel (3) is connected to the ends of a cable (7) which is guided on the upper side of the other panel (2) via deviating rollers (8). The rails consist of hollow profiles into which the rollers (13) of the runner are inserted. The deviating rollers are arranged with their vertical axles (10) between the upper side of the panel (2) and the rails assigned to this panel. Preferred Features: The hollow profiles having wedge-shaped running surfaces (12) on which the runner is centered. The hollow profiles are strand-like profiles or groove profiles.
Patent DK-1227505-T3 (DK)
Inventor: WHYATT MALCOLM
IPC: H01B3/30
Filed: 1998-07-28
Granted: 2005-12-19
Abstract: An electrical insulation material which is suitable for high voltage applications, comprising:     (a) a polymeric material, and (b) an additive incorporated into the polymeric material, the additive comprising a compound of the formula: Rf-O2C(CH2)xCO2-R'f where Rf and R'f are fluorine-substituted aliphatic chains, and x is an integer in the range 9 to 18.
Patent DK-1368990-T3 (DK)
Inventor: BORDEWIJK LOURENS GEORG
IPC: H04R25/02
Filed: 2002-02-15
Granted: 2007-11-05
Abstract: Method for the production of a hearing aid support matched to the auditory meatus of a user. With this method a setting material is introduced into the auditory meatus of the user. After said material has set, a negative is made and after machining this negative, if necessary, and placing the hearing aid, or a substitute for the hearing aid, therein, the support is produced. According to the invention an aid that corresponds to the shape of the universal hearing aid is introduced into the auditory meatus before setting material is introduced into the auditory meatus.
Patent DK-1411956-T3 (DK)
Inventor: ZOPPETTI GIORGIO
IPC: C08B37/00
Filed: 2002-07-26
Granted: 2005-10-24
Abstract: The present invention relates to the use of N,O oversulfated K5 derivatives having a degree of sulfation higher than 3.2 or of their pharmaceutically acceptable salts for the preparation of pharmaceutical compositions for treating the infection and the consequent HIV/ADS disease.
Patent DK-1485652-T3 (DK)
Inventor: HOLDGAARD JENSEN KURT
IPC: H05B1/02
Filed: 2003-03-05
Granted: 2006-09-18
Abstract: System and methods for monitoring an electric range (60). The system has a pleurality of sensing devices including a current meter (30) arranged to measure a current for heating up the electric range, a temperature sensor (22) arranged to measure a temperature of the electric range, a person detector (14) arranged to detect the presence of a person at the electric range and a smoke detector (14; 54) arranged to detect smoke generation from the electric range. A processor (42) having a timer function (44) is operatively connected to the sensor units and is arranged to calculate a heating up state of the electric range according to a program as a function of all the signals from the said detector and their durations and to determine when the heating up state changes into an overheating state calculated as a function of reference values for the said signals and their durations stored in a memory in the processor (42). A switch (36) operatively connected to the processor (42) is arranged to turn off the current for heating up the electric range (60) when the heating up state has changed into the overheating state.
Patent DK-1504035-T3 (DK)
Inventor: POPPLEWELL ANDREW GEORGE
IPC: C12N15/63
Filed: 2003-05-02
Granted: 2010-06-07
Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.
Patent DK-1572463-T3 (DK)
Inventor: WALMSLEY SIMON R
IPC: B41J2/05
Filed: 2003-12-02
Granted: 2011-07-25
Abstract: A controller for a printhead is provided. The printhead has rows of printing nozzles with each nozzle row formed by adjacent sub-rows of printing nozzles of adjacently disposed printhead modules. Each nozzle row us arranged such that the join of the respective adjacent sub-rows is arbitrarily located relative to the other nozzle rows thereby forming an arbitrarily shaped join region. The controller being configured to determine the arbitrary shape of the join region and to supply dot data to the printhead which compensates for the determined arbitrary shape.
Patent DK-1787369-T3 (DK)
Inventor: PIERCE ANDREW ELIOT
IPC: G02B6/50
Filed: 2005-08-26
Granted: 2012-02-27
Abstract: A system, device, fiber optic cable and/or method for hauling fiber optic cable along a conduit to a location. The system includes a fiber optic cable including an optic fiber, at least one first strengthening element and at least one second strengthening element, an optic connector attached to the at least one first strengthening element and able to be optically aligned with the optic fiber; and, a hauling shroud, including a cavity to receive the optic connector, a locking mechanism to removably hold the at least one second strengthening element and a member for attaching a hauling rope or cable to pull the fiber optic cable along the conduit.
Patent DK-1797755-T3 (DK)
Inventor: VAN DEN BERG KAREL
IPC: A01J5/017
Filed: 2006-12-04
Granted: 2009-11-30
Abstract: A method of milking an animal. The method comprises the steps of admitting the animal into a milking box and expelling the animal from the milking box, the milking box comprising a connecting device, such as a robot arm, for automatically connecting a teat cup to a teat of the animal. The step of expelling the animal from the milking box is carried out by means of the robot arm. An installation for milking an animal, the installation being provided with a milking box for the animal; a robot arm for automatically connecting a teat cup to a teat of the animal; and a device for expelling the animal from the milking box. The device for expelling the animal from the milking box comprises the robot arm.
Patent DK-1943173-T3 (DK)
Inventor: SCHNEIDER MARCEL
IPC: B65H3/08
Filed: 2006-10-02
Granted: 2011-10-31
Abstract: The method according to the invention of transferring stacked, sheet-like, flexible products (10), in particular printed products (12), to a belt conveyor (20) has a gripper (26) by means of which the product (10) at the bottom of the stack of products in each case is conveyed from a receiving region into a transfer region (19). In the transfer region, the product (10) is deposited on the belt conveyor (20). In order to accelerate the product as quickly as possible to the speed, and in the conveying direction (F), of the belt conveyor (20), the method has a contact-pressure roller (54) which follows the gripper (26) in the transfer region (19). This contact-pressure roller (54) presses the product (10) onto the belt conveyor (20), the gripper (26) releasing the product (10) at least more or less at the same time as the operation of pressing the product onto the conveying belt (64) of the belt conveyor (20) commences.
Patent DK-2086755-T3 (DK)
Inventor: DRILLET PASCAL
IPC: B32B15/00
Filed: 2006-10-30
Granted: 2018-01-22
Abstract: Coated steel having a well defined and uniform thickness is useful and advantageous for preparing products by hot stamping. Products prepared by hot stamping such a steel are particularly advantageous when subjected to a subsequent spot welding step.
Patent DK-1865017-T3 (DK)
Inventor: TAEGE REINER REINHARD WILHELM
IPC: C08J7/12
Filed: 2007-05-14
Granted: 2011-03-14
Abstract: Antioxidants such as nitric oxide (NO) are used as embrittlement inhibitors for surface fluorinated plastics materials.
Patent DK-2167093-T3 (DK)
Inventor: SHIN JEE-HYUN
IPC: A61K9/14
Filed: 2008-06-03
Granted: 2012-06-25
Abstract: Disclosed herein is a therapeutic agent for chronic heart failure comprising, as an effective ingredient, 5-[2-propyloxy-5-(1-methyl-2-pyrrolidinyl-ethylamidosulfonyl)phenyl]-1-methyl-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidine-7-one. The compound inhibits phosphodiesterase-5 (PDE-5), which catalyzes the intracellular degradation of cyclic guanosine monophosphatase (cGMP), thereby mitigating several signs of chronic heart failure, that is, thereby preventing left ventricular dilatation, decreasing ventricular wall thinning, lowering elevated cardiac and circulating levels of atrial natriuretic peptide (ANP), and inhibiting ventricular fibrosis. Also, the compound has advantages in that it reaches the maximal plasma level in a short time, has an in vivo half-life longer than conventional PDE-5 inhibitors, allowing decreased administration frequency, and has fewer side effects, thus ensuring safety. Thus, the compound is useful as a therapeutic agent for chronic heart failure.
Patent DK-2203181-T3 (DK)
Inventor: KHEDKAR ANAND
IPC: A61K38/28
Filed: 2008-10-16
Granted: 2018-05-28
Abstract: The invention relates to improvised pharmaceutical compositions permitting ingestion via oral delivery of proteins/peptides or their conjugates, and/or cation-insulin conjugate complexes demonstrating desirable pharmacokinetic profiles and potency in efficacy models of diabetes in dogs and humans. A preferred formulation comprises 0.01% - 20% w/w of insulin, insulin compound conjugates and/or cation insulin conjugates, 10% - 60% w/w of one or more fatty acid components selected from saturated or unsaturated C4-C12 fatty acids and/or salts of such fatty acids and additionally contains optimal amounts of other pharmaceutically suitable polymer excipients which permit improved solubility, dissolution rate and effective bioavailability of poorly water soluble compositions and consistent in-vivo release profiles upon scalability during manufacture. A further aspect of the invention features the process of preparing the aforesaid formulations.
Patent DK-2116878-T3 (DK)
Inventor: DE MONTMORILLON LOUIS-ANNE
IPC: G02B6/036
Filed: 2009-05-05
Granted: 2012-03-05
Abstract: A single mode optical fiber includes, from the center towards the periphery, a central core, an intermediate cladding, a depressed trench, and an external optical cladding. The central core has a radius r 1  and a positive index difference n 1  with the optical cladding; the intermediate cladding has a radius r 2  and a positive index difference n 2  with the optical cladding, wherein n 2  is less than the index difference n 1  of the core. The depressed trench has a radius r 3  and a negative index difference n 3  with the optical cladding. The optical fiber has a mode field diameter (MFD) between 8.6 µm and 9.5 µm at a wavelength of 1310 nanometers, and for a wavelength of 1550 nanometers, the fiber has bending losses less than 0.25 x 10 -3  dB/turn for a radius of curvature of 15 millimeters. The length of fiber required for the attenuation of the LP11 mode to reach 19.3 dB at a wavelength of 1260 nanometers is less than 90 meters. Such a fiber can be used in a difficult environment such as miniaturized optical boxes.
Patent DK-2268823-T3 (DK)
Inventor: BROEKER MICHAEL
IPC: C12P5/02
Filed: 2009-08-28
Granted: 2011-10-03
Abstract: A method for preparing purified yeast is disclosed, where the squalene source is a yeast that hyper-produces squalene. The squalene is useful for pharmaceutical purposes. For instance, it can be used to prepare an oil-in-water emulsion, and the emulsion is particularly suitable for use as an immunological adjuvant.
Patent DK-2251330-T3 (DK)
Inventor: WENTLAND MARK P
IPC: A61K31/485
Filed: 2005-11-03
Granted: 2012-08-06
Abstract: 4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
Patent DK-2933262-T3 (DK)
Inventor: Abrahmsén Lars
IPC: C07K14/43
Filed: 2011-07-08
Granted: 2018-06-25
Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for treatment or diagnosis of disease in mammals including humans.